搜尋結果
Amgen jumps after teasing weight-loss drug data, rival stocks fall
Reuters· 3 日前... new tab fell 2.3%. , opens new tab is conducting mid-stage studies of the injectable drug ...
Denmark to restrict Ozempic, other GLP-1 drugs, to treat type 2 diabetes
Reuters· 6 日前... new patients suffering from type 2 diabetes began treatment with a reimbursed GLP-1 drug ...
Novo Nordisk beats profit estimates as sales of weight loss drug Wegovy more than double
CNBC· 5 日前Net profit rose 28% year-on-year to 25.4 billion Danish kroner ($3.65 billion), versus analyst ...
Supplements' quality scandals dampen trust
China Daily· 55 分鐘前Recent quality scandals involving Japanese pharmaceutical companies have raised concerns among many Chinese tourists and ...
Amgen 'encouraged' by weight-loss drug interim data, shares jump
Reuters· 4 日前, opens new tab on Thursday said it was very encouraged after completing an interim analysis of ...
Pot Stocks Surge on Report DEA Set to Reclassify Marijuana
Bloomberg· 6 日前... our reporters? Shares of cannabis-related companies jumped Tuesday after the US Drug ... ...
CVS Caremark’s Policy Shift On Humira Biosimilars May Not Be What The Doctor Ordered
Forbes· 5 日前As of March, the blockbuster autoimmune drug Humira (adalimumab) still held 96% of the market ...
Here Are the Obesity Drug Hopefuls Vying to Unseat Ozempic, Zepbound
Bloomberg· 4 日前Insatiable demand for weight-loss drugs has made the market so feverish that any positive ...
Amgen investors await weight-loss drug data
Reuters· 6 日前, opens new tab investors eyeing dramatic share price gains for rivals with successful obesity ...
Novo Slides as Amgen Fuels Obesity Drug Competition Fears
Bloomberg· 4 日前Have a confidential tip for our reporters? Novo Nordisk A/S shares fell as a US rival’s ...